ALB and hypertensive disorder: In a study of an Asian population with hypertension combined with CKD, sacubitril valsartan reduced systolic blood pressure by 20.5 mm Hg and urinary albumin/creatinine ratio (UACR) by a significant 15.1% in patients with hypertension combined with CKD (61).